pandemic influenza vaccine h5n1 baxter ag
resilience biomanufacturing ireland limited - εμβόλιο κατά της γρίπης (ολόκληρο ιοσωμάτιο, αδρανοποιημένο) που περιέχει αντιγόνο: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - Εμβόλια - Προφύλαξη της γρίπης σε επίσημα δηλωμένη πανδημική κατάσταση. Το εμβόλιο πανδημικής γρίπης πρέπει να χρησιμοποιείται σύμφωνα με τις επίσημες οδηγίες.
propofol/baxter inj.em.in 10mg/ml
baxter holding b.v., the netherlands kobaltweg 49, 3542ce utrecht - propofol - inj.em.in (ΓΑΛΑΚΤΩΜΑ ΓΙΑ ΕΓΧΥΣΗ Η ΕΝΕΣΗ) - 10mg/ml - propofol 10mg - propofol
bortezomib/baxter pd.inj.sol 3.5mg/vial
baxter holding b.v., the netherlands kobaltweg 49, 3542ce utrecht - bortezomib - pd.inj.sol (ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 3.5mg/vial - bortezomib 3,5mg - bortezomib
paracetamol/baxter sol.inf 10mg/ml
baxter holding b.v., the netherlands kobaltweg 49, 3542ce utrecht - paracetamol - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - 10mg/ml - paracetamol 10mg - paracetamol
pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - Αντινεοπλασματικοί παράγοντες - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
dexmedetomidine/baxter c/s.sol.in 100mcg/ml
baxter holding b.v., the netherlands kobaltweg 49, 3542ce utrecht - dexmedetomidine hydrochloride - c/s.sol.in (ΠΥΚΝΟ ΔΙΑΛΥΜΑ ΓΙΑ ΠΑΡΑΣΚΕΥΗ ΔΙΑΛΥΜΑΤΟΣ ΠΡΟΣ ΕΓΧΥΣΗ) - 100mcg/ml - dexmedetomidine hydrochloride 118mcg - dexmedetomidine
dexmedetomidine/baxter 100mcg/ml concentrate for solution for infusion
baxter holding b.v. (0000011218) kobaltweg 49, utrecht, 3542 ce - dexmedetomidine hydrochloride - concentrate for solution for infusion - 100mcg/ml - dexmedetomidine hydrochloride (145108583) 118ug
paracetamol/baxter 10mg/ml solution for infusion
baxter holding b.v. (0000011218) kobaltweg 49, utrecht, 3542 ce - paracetamol - solution for infusion - 10mg/ml - paracetamol (0000103902) 10mg
bortezomib/baxter 3.5mg powder for solution for injection
baxter holding b.v. (0000011218) kobaltweg 49, utrecht, 3542 ce - bortezomib - powder for solution for injection - 3.5mg - bortezomib (8000002750) 3,5mg
metronidazole/baxter inj.so.inf 500mg/100ml bag
baxter hellas ΕΠΕ Μαρίνου Αντύπα 47 & Ανάφης, 141 21 Ν. Ηράκλειο 210.2880000 - metronidazole - inj.so.inf (ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΔΟΦΛΕΒΙΑ ΕΓΧΥΣΗ) - 500mg/100ml bag - metronidazole 5mg - metronidazole